Literature DB >> 4065177

The relationship of cyst type to risk factors for breast cancer and the subsequent development of breast cancer in patients with breast cystic disease.

J M Dixon, A B Lumsden, W R Miller.   

Abstract

The frequency of epithelial hyperplasia and papillary apocrine change in patients with palpable breast cysts lined by either apocrine or flattened epithelium has been compared. Hyperplasia of any degree, severe hyperplasia with or without atypia and papillary apocrine change were all seen significantly more frequently in patients with clinically palpable apocrine cysts. Twelve patients were identified with breast cancer with a history of cyst aspiration, in whom all cysts aspirated could be classified as apocrine or flattened on the basis of cytology or electrolyte composition of cyst fluid. Eleven patients had single or multiple apocrine cysts and one had a single flattened cyst. This represents a significantly increased preponderance of apocrine cysts as compared with that normally seen in patients with cystic disease. The mastectomy specimens of those 11 patients with a history of apocrine cyst aspiration more frequently contained hyperplastic changes and non-invasive carcinoma than age- and menopausal-matched controls who did not have a history of cystic disease. This study suggests that patients who develop cysts lined by apocrine epithelium may be at a greater risk of subsequent breast cancer than those with flattened epithelial cysts.

Entities:  

Mesh:

Year:  1985        PMID: 4065177     DOI: 10.1016/0277-5379(85)90289-5

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  17 in total

Review 1.  Biochemical study of cyst fluid in human breast cystic disease: a review.

Authors:  C L Enriori; J E Novelli; M del C Cremona; R J Hirsig; P J Enriori
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

2.  Apolipoprotein D is the major protein component in cyst fluid from women with human breast gross cystic disease.

Authors:  M Balbín; J M Freije; A Fueyo; L M Sánchez; C López-Otín
Journal:  Biochem J       Date:  1990-11-01       Impact factor: 3.857

3.  Differential distribution of soluble and complexed forms of prostate-specific antigen in cyst fluids of women with gross cystic breast disease.

Authors:  M Malatesta; F Mannello; M Sebastiani; G Gazzanelli
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

4.  Immunohistochemical localisation of androgen receptor in apocrine metaplasia and apocrine adenosis of the breast: relation to oestrogen and progesterone receptors.

Authors:  A G Selim; C A Wells
Journal:  J Clin Pathol       Date:  1999-11       Impact factor: 3.411

5.  Determination of growth fractions in benign breast disease (BBD) with monoclonal antibody Ki-67.

Authors:  R J Lellé; W Heidenreich; G Stauch; I Wecke; J Gerdes
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

6.  Lipid-associated sialic acid levels in human breast cyst fluids.

Authors:  F Mannello; G Bocchiotti; R Troccoli; G Gazzanelli
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

Review 7.  Non-operative breast pathology: apocrine lesions.

Authors:  C A Wells; G A El-Ayat
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411

8.  Quantification of prostate-specific antigen immunoreactivity in human breast cyst fluids.

Authors:  F Mannello; G Bocchiotti; G Bianchi; F Marcheggiani; G Gazzanelli
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

9.  Epidermal growth factor content of breast cyst fluids from women with breast cancer or proliferative disease of the breast.

Authors:  R Torrisi; S Zanardi; F Pensa; G Valenti; V De Franchis; G Nicolo; A Barreca; F Minuto; F Boccardo
Journal:  Breast Cancer Res Treat       Date:  1995-03       Impact factor: 4.872

10.  Relationship between epidermal growth factor and dehydroepiandrosterone and its sulphate in breast cyst fluid.

Authors:  L C Lai; M W Ghilchik; N A Shaikh; M J Reed; V H James
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.